TrialMolecular systems biology2021

Combined metabolic activators therapy ameliorates liver fat in nonalcoholic fatty liver disease patients.

Mujdat Zeybel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.